Recruiting NCT00616317
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Antiphospholipid Syndrome. Basic parameters: 1 Minute — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Primary outcome measures
- Long term survival [Time frame: 10 year]
Eligibility criteria
Inclusion criteria
- 18 years of age or younger at the onset of disease
- Presence of Vascular Thrombosis
- UC Davis patient
- Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma
Exclusion criteria
- Infants born to mothers with APS
- Infants with congenital thrombophilia
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- UC Davis Medical Center — Sacramento
Identifiers
NCT: NCT00616317 · 235519